Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Did you Double your money in 2020

<< Previous

Bullboard Posts

Next >>

Comment by YukonJezzaon Dec 18, 2020 5:32am

98 Views

Post# 32138110

RE:RE:Did you Double your money in 2020

Layth1990 wrote:
I doubled my money with Chorus avation and invested all in Ate at 3.94Cad 3 days ago.
guess what? bang its going to hell haha

i'm sure it will go up eventually and i can wait

I'm just cautious with a company that suggests it will be almost 3x the value by end of year ....yet insiders ditch 5 million shares. Just be careful,. Also There is a minimum $SP to join Nasdaq which currently Ate is not yet met. ($5.00 I believe) so why the lowball reverse SP split earlier?? Could have voted on a new reverse Split of 15:1

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec